MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression

Paclitaxel (Taxol) is an effective chemotherapeutic agent for treating breast cancer patients. However, chemoresistance is a major obstacle in cancer treatment. Here, we showed that overexpression of miR-16 promoted Taxol-induced cytotoxicity and apoptosis in breast cancer cells. Furthermore, IκB ki...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Xueyuan, Jin, Long, Cao, Peiguo, Cao, Ke, Huang, Chenghui, Luo, Yanwei, Ma, Jian, Shen, Shourong, Tan, Ming, Li, Xiayu, Zhou, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029655/
https://www.ncbi.nlm.nih.gov/pubmed/26993770
http://dx.doi.org/10.18632/oncotarget.8056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029655/
https://www.ncbi.nlm.nih.gov/pubmed/26993770
http://dx.doi.org/10.18632/oncotarget.8056

Ejemplares similares